Legal overreaction to SCOTUS ban on race fueling loss of med school diversity

One admissions officer called the enrollment declines "staggering."

January 23, 2025 Check out STAT+

Sponsored By

Adobe Legal overreaction to Supreme Court ban on race fueling loss of diversity at medical schools Response to the court decision has been "overzealous," say some experts, and there are still legal strategies that could diversify enrollment. By Usha Lee McFarling Trump executive order declaring only 'two sexes' gets the biology wrong, scientists say Executive order gets basic biology wrong – sex is not determined at conception – and ignores research on fetal development By Megan Molteni Sacklers reach new $7.4 billion settlement over opioid crisis Previous $6 billion settlement scuttled by Supreme Court over Sackler family protection from OxyContin litigation. Family will give up company control. By Ed Silverman Julia Demaree Nikhinson/AP Opinion: Allowing ICE in hospitals is a public health catastrophe in the making "ICE's incursions into hospitals are a direct attack on the foundational principles of medical ethics and public health," writes Eric Reinhart. By Eric Reinhart Trump administration's abrupt cancellation of scientific meetings prompts confusion, concern The scope of the cancellations was unclear, but researchers worried that NIH funding and scientific updates to the public could be affected. By Anil Oza STAT+ | RFK Jr., an investor in a CRISPR biotech, has raised alarms about the technology His comments about the gene-editing technology raise a question about how he would regulate it as head of HHS. By Jonathan Wosen Chinese biotechs, a WHO departure, and post-JPM thoughts This episode, we go over our closing thoughts from the J.P. Morgan Healthcare Conference, including the chatter around Chinese drugs. By Allison DeAngelis, Elaine Chen, and Adam Feuerstein Opinion: 'Rationing by inconvenience': Health insurers count on customers not appealing denials Far too many Americans to go without prescribed care because of the inconveniences and stresses of the insurance appeal process. By Miranda Yaver

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser